000513 Livzon Pharmaceutical Group Inc.
- 39.00
- -0.66-1.66%
Livzon Pharmaceutical Group Inc. News
Livou Group: Announcement on approval of new indications for injectable triprorelin acetate microspheres
Pearl Group: Announcement on the completion of fund-raising investment projects and permanently supplementing working capital with savings raised
Pearl Group: Announcement on the Action Plan for Double Improvement of Quality and Return
Livzon Pharmaceutical Group Inc.: Financial Report for the first half of 2024.
Livzon Pharmaceutical Group Inc.: Summary table of non-operating funds utilization and other related funds flow for the first half of the year.
Livzon Pharmaceutical Group Inc.: Announcement of Foreign Investment
Livzon Pharmaceutical Group Inc.: Annual dividend for the period ending December 31, 2023.
Livzon Pharmaceutical Group Inc.: Legal Opinion of Guangdong Desai Law Firm on the Shareholders' Meeting of Livzon Pharmaceutical Group Inc. for the Year 2023, the First A-Shareholders' Meeting for the Year 2024 and the First H-Shareholders' Meeting for the Year 2024
Livzon Pharmaceutical Group Inc.: Announcement of Resolutions of the 2023 Shareholders' Meeting, the 2024 First A Shareholders' Meeting and the 2024 First H Shareholders' Meeting held by the Company.
Livzon Pharmaceutical Group Inc.: Notice of acceptance of registration and listing application for Simeglurant Injection.
Livzon Pharmaceutical Group Inc.: An indicative announcement on the expiration of the lockdown period for the first phase of the shareholding plan for medium- and long-term business partners
Livzon Pharmaceutical Group Inc.: Notice on holding the 2023 Annual General Meeting of Shareholders and the First Class A Share Shareholders' Meeting in 2024
Livingstone Group: Internal Control Self-Assessment Report
Pearl Group: Announcement on Launching Futures Hedging Business
Pearl Group: Announcement on Launching Foreign Exchange Derivatives Trading Business
Pearl Group: Rules of Procedure for the Board of Directors
Livingzhu Group: Legal Opinion of Guangdong Desai Law Firm on the 2024 Second Extraordinary General Meeting of Shareholders of Livingzhu Pharmaceutical Group Co., Ltd.
Pearl Group: Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders
Pearl Group: Notice on Convening the Second Extraordinary General Meeting of Shareholders in 2024
Pearl Group: Announcement on the Appointment of Senior Executives
Analysis
Price Target
No Data
No Data